Research & KnowledgeEvent: September 2, 2026
Myogenes published evidence showing that ACKR1/Duffy-null genotype testing in national suicide prevention and mental health strategy can be recognized as an enabler of timely clozapine access.
Published
Signal category
Research & Knowledge
Quote
“Recognise genotype testing in national suicide prevention and mental health strategy — as an enabler of timely clozapine access, not a standalone intervention.”
— Marc Howells|Myogenes team
Company
Myogenes
Helping GPs and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing
- Industry
- Medical Practices
- Location
- Elstree, GB
- Company size
- 13 employees
Helping GP's and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing | Cancer Testing | Pharmacogentic Testing
Founded 2016